Atenolol and Chlorthalidone
Atenolol and Chlorthalidone is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Atenolol and Chlorthalidone; Generic name: ATENOLOL AND CHLORTHALIDONE; Drug class: beta-Adrenergic Blocker [EPC].
| Brand name | Atenolol and Chlorthalidone |
|---|---|
| Generic name | ATENOLOL AND CHLORTHALIDONE |
| Drug class | beta-Adrenergic Blocker [EPC] |
| Manufacturer | Northstar Rx LLC. |
| Used for | INDICATIONS AND USAGE Atenolol and chlorthalidone tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including atenolol and chlorthalidone. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than |
| Dosage | DOSAGE AND ADMINISTRATION DOSAGE MUST BE INDIVIDUALIZED (See INDICATIONS AND USAGE ). Chlorthalidone is usually given at a dose of 25 mg daily; the usual initial dose of atenolol is 50 mg daily. Therefore, the initial dose should be one atenolol and chlorthalidone 50mg/25mg tablet given once a day. If an optimal response is not achieved, the dosage should be increased to one atenolol and chlorthalidone 100mg/25mg tablet given once a day. When necessary, another antihypertensive agent may be adde |
| Warnings | WARNINGS Cardiac Failure Sympathetic stimulation is necessary in supporting circulatory function in congestive heart failure, and beta blockade carries the potential hazard of further depressing myocardial contractility and precipitating more severe failure. IN PATIENTS WITHOUT A HISTORY OF CARDIAC FAILURE, continued depression of the myocardium with beta-blocking agents over a period of time can, in some cases, lead to cardiac failure. At the first sign or symptom of impending cardiac failure, |
| Active ingredient(s) | ATENOLOL |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1494d5f7-8620-46da-8bca-69b76cd17635 |